RecruitingNCT07221877
Effect of KarXT on Urological Safety
This study is recruiting in the United States. It focuses on Schizophrenia.
Multiple locations, including Little RockSchizophreniaOtherFrom 18 Years to 65 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
RecruitingNCT07610473
Effectiveness of DT-101 in depression
This study is recruiting in the United States. It is testing DT-101 for depression.
Multiple locations, including DeSotoDepressionOtherFrom 18 Years to 75 Years
RecruitingNCT07300969
Effectiveness of DT-101 in depression
This study is recruiting in the United States, in the United Kingdom, in Bulgaria, .... It is testing DT-101 for depression.
Multiple locations, including BentonvilleDepressionOtherFrom 18 Years to 75 Years
RecruitingNCT07105111
Effectiveness of valbenazine in adults with tardive dyskinesia
This study is recruiting in the United States. It focuses on adults with tardive dyskinesia who remain symptomatic while receiving or after stopping a VMAT2 inhibitor.
Multiple locations, including BryantSchizophrenia, Depression, ...DrugA study involving a medication or substance.Over 18 Years
RecruitingNCT07380412
Effects of a Supplement on the Side Effects Associated With Stimulant Medications
This study is recruiting in the United States. It focuses on ADHD.
In Las VegasADHDOtherFrom 18 Years to 55 Years
RecruitingNCT07140913
KarXT for manic episodes in bipolarity type I
This study is recruiting in the United States, in France, in Argentina, .... It is testing KarXT for manic episodes in bipolarity type I, including participants taking lithium, valproate, or lamotrigine.
Multiple locations, including BentonvilleBipolarityDrugFrom 18 Years to 65 Years
RecruitingNCT07227454
Esketamine for depression
This study is recruiting in the United States, in Brazil, in Hungary, .... It is testing esketamine for depression.
Multiple locations, including BirminghamDepressionOtherFrom 12 Years to 17 Years
RecruitingNCT06951698
KarXT for manic episodes in bipolarity type I
This study is recruiting in the United States, in Australia, in New Zealand, .... It is testing KarXT for manic episodes in bipolarity type I.
Multiple locations, including BentonvilleBipolarityDrugFrom 18 Years to 65 Years
RecruitingNCT06951711
KarXT for manic episodes in bipolarity type I
This study is recruiting in the United States, in Croatia, in India, .... It is testing KarXT for manic episodes in bipolarity type I.
Multiple locations, including Little RockBipolarityDrugFrom 18 Years to 65 Years
RecruitingNCT07288567
KarXT for schizophrenia
This study is recruiting in the United States, in Argentina, in Colombia, .... It is testing KarXT for schizophrenia.
Multiple locations, including AnaheimSchizophreniaOtherFrom 13 Years to 17 Years
RecruitingNCT06882785
KarXT for schizophrenia
This study is recruiting in Japan. It is testing KarXT for schizophrenia.
Multiple locations, including KōnanSchizophreniaOtherFrom 18 Years to 65 Years
RecruitingNCT07065240
SPT-300 (GlyphAllo) for depression
This study is recruiting in the United States, in Bulgaria, in Czechia, .... It is testing SPT-300 (GlyphAllo) for depression.
Multiple locations, including ChinoDepressionOtherFrom 18 Years to 65 Years
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.